Ignite Creation Date:
2024-05-06 @ 4:21 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04968964
Status:
RECRUITING
Last Update Posted:
2024-06-06
First Post:
2021-07-08
Brief Title:
Treatment Monitoring of Patients Receiving CDK 46 Inhibitors for Hormone Receptor HR Positive HER2 Negative Metastatic Breast Cancer MBC With or Without the Addition of DiviTum Serum Thymidine Kinase 1 TK1 Activity Testing
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-08
First Submit QC Date:
July 8 2021
Study First Post Date:
2021-07-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-04
Last Update Post Date:
2024-06-06
Last Update Post Date Type:
ACTUAL